Co-tenidone

Revision as of 18:42, 27 September 2011 by WikiBot (talk | contribs) (Protected "Co-tenidone": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Co-tenidone
Combination of
AtenololBeta blocker
ChlortalidoneThiazide diuretic
[[{{{component3}}}]]? Class
[[{{{component4}}}]]? Class
[[{{{component5}}}]]? Class
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • UK: POM (Prescription only)
Identifiers
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

Co-tenidone (BAN) is a non-proprietary name used to denote a combination of atenolol and chlortalidone. Co-tenidone is used in the treatment of hypertension. The use of β-blockers in hypertension was downgraded in June 2006 in the United Kingdom to fourth-line as they perform less well than other drugs, and that atenolol, the most frequently used β-blocker, at usual doses carries an unacceptable risk of provoking type 2 diabetes.[1]

Formulation

Two strengths of co-amilozide is currently available in the UK:

  • 50 mg atenolol and 12.5 mg chlortalidone , BAN of Co-tenidone 50/12.5
  • 100 mg atenolol and 25 mg chlortalidone , BAN of Co-tenidone 100/25

References

Footnotes

  1. Sheetal Ladva (28/06/2006). "NICE and BHS launch updated hypertension guideline". National Institute for Health and Clinical Excellence. Check date values in: |date= (help)